LGALS3 and hyperlipidemia: The baseline analysis showed higher concentration of Gal-3 in patients diagnosed with hyperlipidemia (44 patients, 40%) compared to patients without lipid disorders (66 patients, 60%) (14.7 ± 6.8 ng/mL vs. 10.7 ± 4.2 ng/mL, p = 0.01).